Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001004256 | SCV001163132 | likely pathogenic | Cystic fibrosis; Congenital bilateral aplasia of vas deferens from CFTR mutation | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV000583796 | SCV002614657 | pathogenic | Cystic fibrosis | 2017-10-02 | criteria provided, single submitter | clinical testing | The p.K381* pathogenic mutation (also known as c.1141A>T), located in coding exon 9 of the CFTR gene, results from an A to T substitution at nucleotide position 1141. This changes the amino acid from a lysine to a stop codon within coding exon 9. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Clinical Molecular Genetics Laboratory, |
RCV000583796 | SCV000692320 | pathogenic | Cystic fibrosis | 2015-10-29 | no assertion criteria provided | clinical testing |